Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Cancer

• Publication date

  1991-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19910215)67:4<915::AID-CNCR2820670410>3.0.CO;2-8PMID 1703916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized comparison of two chemotherapy, radiotherapy schemes for stage iii and iv unresectable squamous cell carcinoma of the head and neck

  1990cited by this paper
• Dear Editor

  1990cited by this paper
• Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck.

  1989cited by this paper
• Experimental and clinical studies alternating chemotherapy and radiotherapy

  1989cited by this paper
• Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer.

  1989cited by this paper
• Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.

  1988cited by this paper
• Alternating Cisplatin‐5-Fluorouracil and Radiotherapy in Head and Neck Cancer

  1988cited by this paper
• Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern California oncology group

  1987cited by this paper
• Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

  1987cited by this paper
• Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program.

  1986cited by this paper
• Combined polychemotherapy and radiotherapy in advanced inoperable squamous cell carcinoma of the head and neck.

  1985cited by this paper
• Multidrug chemotherapy (vincristine, bleomycin, and methotrexate [VBM]) with radiotherapy in stage III-IV squamous cell carcinoma of the head and neck.

  1984cited by this paper
• Combined radiotherapy and CMF-B cytotoxic regimen in stage III-IV head and neck squamous cell carcinoma.

  1984cited by this paper
• Long-term results of VBM and radiotherapy in advanced head and neck cancer.

  1982cited by this paper
• Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx.

  1980cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• Fleiss, J. L.: Statistical Methods for Rates and Proportions. John Wiley & Sons, New York‐London‐Sydney‐Toronto 1973. XIII, 233 S.

  1974cited by this paper
• Statistical Methods for Rates and Proportions

  1974cited by this paper
• A simplification in the use of the NSD concept in practical radiotherapy.

  1973cited by this paper
• Cancer of the head and neck.

  1972cited by this paper
• Treatment of advanced cancer of the head and neck

  1970cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• The Journal of Laryngology and Otology Prospectives in head and neck oncology

  year unknowncited by this paper

• A randomized, controlled trial to investigate cognitive behavioral therapy in prevention and treatment of acute oral mucositis in patients with locoregional advanced nasopharyngeal carcinoma undergoing chemoradiotherapy

  2023cites this paper
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

  2021cites this paper
• Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

  2021cites this paper
• Salivary Lactate Dehydrogenase (LDH) as a Marker for Radiation-induced Mucositis in Head and Neck Cancers: A Preliminary Study

  2019cites this paper
• Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma

  2015cites this paper
• Oral complications in patients receiving head and neck radiation therapy: a literature review

  2014cites this paper
• Evaluation of Neo-Adjuvant, Concurrent and Adjuvant Chemotherapy in the Treatment of Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

  2014cites this paper
• Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality

  2013cites this paper
• Strategies for Non-Resectable Head and Neck Cancer

  2013cites this paper
• Chemioterapia e terapie mirate nel trattamento delle neoplasie delle vie aerodigestive superiori (escluso il linfoma maligno)

  2012cites this paper
• Head and Neck Cancer

  2012cites this paper
• Alternating Combination Chemotherapy and Radiotherapy in Locoregionally Advanced Head and Neck Cancer

  2012cites this paper
• Chimiothérapie et thérapeutiques ciblées dans le traitement des cancers des voies aérodigestives supérieures (lymphome malin exclu)

  2012cites this paper
• Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis.

  2012cites this paper
• Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

  2011cites this paper
• A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.

  2010cites this paper
• Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

  2010cites this paper
• Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).

  2009cites this paper
• Ocena dysfunkcji dużych gruczołów ślinowych u chorych napromienianych z powodu nowotworów rejonu głowy i szyi

  2009cites this paper
• Effect of Low Level Laser Therapy During the Treatment of Chemotherapy Induced Oral Mucositis in Postmenopausal Breast Cancer

  2008cites this paper
• Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy

  2008cites this paper
• Dose escalation study of nedaplatin with 5-fluorouracil in combination with alternating radiotherapy in patients with head and neck cancer.

  2007cites this paper
• Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.

  2007cites this paper
• Taxane‐based chemoirradiation for organ preservation with locally advanced head and neck cancer: Results of a phase II multi‐institutional trial

  2007cites this paper
• Comparison of sequential chemoradiation with radiation alone in the treatment of advanced head and neck cancers

  2006cites this paper
• Future chemotherapy and radiotherapy options in head and neck cancer

  2006cites this paper
• Lippen-, Mundhöhlen- und Oropharynxtumoren

  2006cites this paper
• FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.

  2006cites this paper
• Functinal and aesthetic outcome of reconstruction of large oro-facial defects involving the lip after tumor resection.

  2006cites this paper
• Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

  2006cites this paper
• [Radiation-induced mucositis of the aerodigestive tract: prevention and treatment. MASCC/ISOO mucositis group's recommendations].

  2006cites this paper
• Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.

  2006cites this paper
• Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative?

  2006cites this paper
• Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615.

  2005cites this paper
• Combined effect of heptaplatin and ionizing radiation on human squamous carcinoma cell lines.

  2005cites this paper
• Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma

  2005cites this paper
• Acute toxicity and preliminary clinical outcomes of concurrent radiation therapy and weekly docetaxel and daily cisplatin for head and neck cancer.

  2005cites this paper
• Intra-arterial high-dose chemotherapy with cisplatin as part of a palliative treatment concept in oral cancer.

  2005cites this paper
• Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and Cis-DDP in advanced head and neck cancer: results and toxicity.

  2004cites this paper
• Phase II Trial of Hyperfractionated Accelerated Split-Course Radiochemotherapy with 5-FU and Cis-DDP in Advanced Head and Neck Cancer

  2004cites this paper
• Minimal Residual Disease in Head and Neck Cancer

  2004cites this paper
• Systemic chemotherapy for squamous cell head and neck cancer

  2003cites this paper
• An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

  2003cites this paper
• Hyperfractionated Radiotherapy and Concomitant Cisplatin for Locally Advanced Laryngeal and Hypopharyngeal Carcinomas: Final Results of a Single Institutional Program

  2003cites this paper
• Clinical Trials in Advanced Unresectable Head and Neck Cancer

  2003cites this paper
• Prevention of Radiation-Induced Oral Cavity Mucositis by Plasmid/Liposome Delivery of the Human Manganese Superoxide Dismutase (SOD2) Transgene

  2003cites this paper
• Organ Preservation in Head and Neck Cancer

  2003cites this paper
• Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?

  2003cites this paper
• Radiochemotherapy in head and neck cancer.

  2003cites this paper
• Management of chemo- and radiotherapy induced oral mucositis with low-energy laser: initial results of A.C. Camargo Hospital.

  2003cites this paper
• Uso de diferentes combinaciones de inmunoterapia en pacientes con cáncer recurrente de cabeza y cuello. Experiencia del Instituto Nacional de Cancerología

  2002influential citation
• Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study

  2002cites this paper
• Concurrent Chemotherapy with Carboplatin + 5-Fluorouracil and Radiotherapy in Advanced Squamous Cell Head and Neck Carcinoma: A Retrospective Single Institution's Study

  2001cites this paper
• Unresectable Primary Tumor of Head and Neck: Does Neck Dissection Combined With Chemoradiotherapy Improve Survival?

  2001cites this paper
• Tumores de cabeza y cuello

  2001cites this paper
• Radiothérapie bifractionnée et chimiothérapie par cisplatine et 5-fluoro-uracile concomitantes dans les carcinomes épidermoïdes localement évolués non résécables du pharynx : dix ans d’expérience au centre Antoine Lacassagne

  2001cites this paper
• Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials.

  2001cites this paper
• Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment

  2001cites this paper
• [Concomitant bifractionated radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in locally progressive, non-resectable epidermoid carcinomas of the pharynx: ten years experience at the Antoine Lacassagne center].

  2001cites this paper
• Sequentielle und simultane Radiochemotherapie bei lokal fortgeschrittenen Kopf-Hals-Tumoren

  2001cites this paper
• Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study.

  2000cites this paper
• [Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy].

  2000cites this paper
• The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.

  2000cites this paper
• Combined Radiochemotherapy with Docetaxel in Patients with Unresectable Locally Advanced Head and Neck Tumors

  2000cites this paper
• A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.

  2000cites this paper
• Quimioterapia en el tratamiento de los cánceres de las vías aerodigestivas superiores (linfoma maligno excluido)

  2000cites this paper
• Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).

  2000cites this paper
• A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5‐fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

  1999cites this paper
• Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.

  1999cites this paper
• High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5‐fluorouracil, and bleomycin alternating with methotrexate and epirubicin

  1999cites this paper
• Combined-modality therapy for locoregionally advanced head and neck cancer.

  1999cites this paper
• Altered fractionation in the treatment of head and neck cancer

  1999cites this paper
• Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma.

  1999cites this paper
• Biological and Clinical Implications for Multimodality Treatment in Patients Affected by Squamous Cell Carcinoma of the Head and Neck

  1998cites this paper
• Scoring oral mucositis.

  1998cites this paper
• Ongoing trials in patients with head and neck cancer.

  1997cites this paper
• The role of chemotherapy in head and neck cancer.

  1997cites this paper
• Treatment of squamous cell carcinoma of the esophagus with alternating radiotherapy and chemotherapy (cisplatin, methotrexate, and peplomycin).

  1997cites this paper
• Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial.

  1997cites this paper
• Combined-modality therapy for head and neck cancer.

  1997cites this paper
• Messages from completed randomized trials in head and neck cancer.

  1997cites this paper
• Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseases.

  1997cites this paper
• Preoperative simultaneous chemoradiotherapy in locally advanced cancer of the oral cavity and oropharynx.

  1997cites this paper
• Role of vindesine as neoadjuvant chemotherapy for non-small cell lung and head and neck cancers.

  1997cites this paper
• l Clinical Investigation RADIOTHERAPY AND CONCOMITANT WEEKLY l-HOUR INFUSION OF PACLITAXEL IN THE TREATMENT OF HEAD AND NECK CANCER- RESULTS FROM A PHASE I TRIAL

  1997cites this paper
• Chimiothérapie dans le traitement des cancers des voies aérodigestives supérieures (lymphome malin exclu)

  1997cites this paper
• Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

  1996cites this paper
• Treatment of head and neck cancer: the role of chemotherapy.

  1996cites this paper
• Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C.

  1996cites this paper
• Radiothérapie et chimiothérapie concomitantes comme traitement des cancers des voies aérodigestives supérieures

  1996cites this paper
• Head and neck cancer: guidelines for chemotherapy.

  1996cites this paper
• Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.

  1996cites this paper
• [Concomitant radiotherapy and chemotherapy in the treatment of cancers of the upper respiratory and digestive tracts].

  1996cites this paper
• Head and neck cancer.

  1996cites this paper
• Chemotherapy of squamous cell carcinoma of head and neck: the future is now.

  1996cites this paper
• [Intra-arterial cisplatin and sequential radiotherapy. Long-term follow-up].

  1996cites this paper
• Alternating chemo-radiotherapy in bladder cancer: a conservative approach.

  1995cites this paper
• [Concomitant radiochemotherapy with cisplatin (CDDP), 5-fluorouracil (5-FU) and mitomycin C (MMC) in locally advanced carcinoma of the oropharynx. Results of a phase II trial].

  1995cites this paper
• Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report.

  1995cites this paper
• Head and neck cancer: present status and future prospects of adjuvant chemotherapy.

  1995cites this paper